| 261 |
L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility |
Luigi Margiotta-Casaluci |
BY-SA |
1529: Blockade, L-Type Calcium Channels
|
1535: Heart failure
|
Under Development |
1.45 |
| 260 |
CYP2E1 activation and formation of protein adducts leading to neurodegeneration |
Jelle Broeders |
BY-SA |
2 MIEs
|
1514: Neurodegeneration
|
|
|
| 259 |
Sensitization induction of the intestinal tract by food proteins |
Erwin L Roggen |
BY-SA |
None
|
None
|
|
|
| 258 |
Renal protein alkylation leading to kidney toxicity |
Angela Mally |
BY-SA |
244: Alkylation, Protein
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 257 |
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity |
Angela Mally |
BY-SA |
1486: Binding of substrate, endocytic receptor
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 256 |
Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity |
Angela Mally |
BY-SA |
1481: Inhibition of mitochondrial DNA polymerase gamma (Pol gamma)
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 245 |
Reduction in photophosphorylation leading to growth inhibition in aquatic plants |
Knut Erik Tollefsen |
BY-SA |
1471: Increase, Uncoupling of photophosphorylation
|
1521: Decrease, Growth
|
|
|
| 242 |
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity |
Stefan Scholz |
Open for adoption |
1462: Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts
|
2 AOs
|
|
|
| 241 |
Latent Transforming Growth Factor beta1 activation leads to pulmonary fibrosis |
Marvin Martens |
BY-SA |
1468: Activation, Latent Transforming Growth Factor Beta 1
|
1458: Pulmonary fibrosis
|
|
|
| 240 |
DNA Adducts Leading to Liver Hemangiosarcoma |
Undefined |
BY-SA |
None
|
None
|
|
|
| 239 |
Oxidative Stress Leading to ILC2-mediated Respiratory Epithelial Remodeling |
Undefined |
BY-SA |
None
|
None
|
|
|
| 238 |
Deposition of energy leading to population decline via DNA strand breaks and oocyte apoptosis |
Knut Erik Tollefsen |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 237 |
Substance interaction with lung resident cell membrane components leading to atherosclerosis via acute phase response |
Ulla Vogel |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1443: Atherosclerosis
|
Under Development |
1.55 |
| 236 |
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition |
Timothy Allen |
BY-SA |
1431: Serotonin 1A Receptor Agonism
|
1432: Anti-depressant Activity
|
|
|
| 235 |
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via K Channel Opening |
Timothy Allen |
BY-SA |
1431: Serotonin 1A Receptor Agonism
|
1432: Anti-depressant Activity
|
|
|
| 234 |
Mu Opioid Receptor Agonism leading to Analgesia via Ca Channel Inhibition |
Timothy Allen |
BY-SA |
1425: Mu Opioid Receptor Agonism
|
1428: Analgesia
|
|
|
| 233 |
Mu Opioid Receptor Agonism leading to Analgesia via K Channel Opening |
Timothy Allen |
BY-SA |
1425: Mu Opioid Receptor Agonism
|
1428: Analgesia
|
|
|
| 232 |
NFE2/Nrf2 repression to steatosis |
Lyle Burgoon |
Open for adoption |
1417: NFE2/Nrf2 repression
|
459: Increase, Liver steatosis
|
|
|
| 231 |
presynaptic neuron 2 repression to epilepsy |
Lyle Burgoon |
Open for adoption |
1413: Reduced, presynaptic neuron 2 activity
|
1363: Increased, epilepsy
|
|
|
| 230 |
presynaptic neuron 1 activation to epilepsy |
Lyle Burgoon |
Open for adoption |
1349: Activated, presynaptic neuron 1
|
1363: Increased, epilepsy
|
|
|
| 229 |
Helicobacter pylori to gastric ulcer |
Lyle Burgoon |
Open for adoption |
1412: Helicobacter pylori infection
|
1385: Activated, gastric ulcer formation
|
|
|
| 228 |
NSAID induced PTGS2 inactivation to gastric ulcer |
Lyle Burgoon |
Open for adoption |
1408: Reduced, PTGS2 function
|
1385: Activated, gastric ulcer formation
|
|
|
| 227 |
NSAID induced PTGS1 inactivation to gastric ulcer |
Lyle Burgoon |
Open for adoption |
1402: Reduced, PTGS1 function
|
1385: Activated, gastric ulcer formation
|
|
|
| 226 |
SSRI (Selective serotonin reuptake inhibitor) to hypertension |
Lyle Burgoon |
Open for adoption |
1317: Decreased, serotonin transporter activity
|
1343: Increase, hypertension
|
|
|
| 225 |
Serotonin transporter activation to agitation |
Lyle Burgoon |
Open for adoption |
None
|
1345: Increased, agitation
|
|
|